The peptide —a small protein— beta-amyloid is strongly associated with Alzheimer’s disease; however, researchers are still looking for unequivocal proof that this peptide is the causal agent of the
Research Programmes / Core Facilities
Cell and Developmental Biology
Structural and Computational Biology
Chemistry and Molecular Pharmacology
Core Facilities & Services
Scientists at IRB Barcelona are supported by an extensive range of common core facilities that provide state-of-the-art technologies and scientific services. These facilities are a key asset for our research, allowing the Institute to obtain outstanding results. They are designed to incorporate the most novel technologies available and provide them to our researchers in the shortest time possible.
Selected IRB Barcelona publications
IRB Barcelona's partnerships, with organisations in areas of mutual interest and expertise, aim to take advantage of the wealth of knowledge, resources and technologies so critical to advancing the field of biomedicine
News & Events
Laying siege to beta-amyloid, the key protein in Alzheimer’s disease
IRB Barcelona receives the support of the ERC to develop a test to predict metastasis of colon and liver cancer
New angles on Alzheimer’s disease
Researchers measure a property of DNA for the first time
02OctFrom luminescent molecular probes to cellular stains
03OctFrom sequence reads to disease mechanisms modeling biological networks
03OctA Periodic Table of Protein Complexes
08OctTomB/YmoB: anoxygen-dependent toxin-antitoxin system regulating biofilm formation
Today the European Research Council (ERC) has announced the “Proof of Concept” awards for 50 European projects.
The Spanish Society of Neurology estimates that 600,000 people are affected by Alzheimer’s disease in this country.
The researchers have succeeded by using their own technique, recently developed at IBEC, based on electrostatic force microscopy (EFM).
Speaker: Dr. Joaquin Dopazo,
Computational Genomics Department, Centro de Investigación Príncipe Felipe, Valencia, Spain
Speaker: Sarah Teichmann,
EMBL-EBI, The European Bioinformatics Institute, Cambridge, UK
Speaker: Dr. Oriol Marimon,
UniversitatAutònomade Barcelona (UAB), Cerdanyola del Vallès, Spain
Speaker: Dr. Dario Valenzano,
Evolutionary and Experimental Biology and Ageing, Max Planck Institute for Biology of Ageing, Cologne, Germany